Results 11 to 20 of about 2,816,049 (194)

Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years - Relationships to hormone replacement therapy [PDF]

open access: yes, 2000
Hormone replacement therapy (HRT) has been shown to increase the relative risk of idiopathic venous thromboembolism (VTE) about threefold in several observational studies and one randomised controlled trial. Whether or not this relative risk is higher in
Rumley, A.   +5 more
core   +8 more sources

Hormone replacement therapy is associated with improved verbal declarative memory in healthy relatively recent postmenopausal women. [PDF]

open access: yes, 2006
The efficacy of Hormone Replacement Therapy (HRT) for cognitive health in postmenopausal women has been systematically questioned during the last decade.
Sünram-Lea, Sandra I.   +3 more
core   +5 more sources

Different effects of oral and transdermal hormone replacement therapies on Factor IX, APC resistance, t-PA, PAI and C- reactive protein - a cross-sectional population survey [PDF]

open access: yes, 2001
The effects of hormone replacement therapy (HRT) on thrombosis risk, thrombotic variables, and the inflammatory marker C- reactive protein (CRP) may vary by route of administration (oral versus transdermal).
Lowe, G.D.O.   +5 more
core   +8 more sources

Randomised controlled trial of an interactive multimedia decision aid on hormone replacement therapy in primary care [PDF]

open access: yes, 2001
Objective To determine whether a decision aid on hormone replacement therapy influences decision making and health outcomes.Design Randomised controlled trial.Setting 26 general practices in the United Kingdom.Participants 205 women considering hormone ...
Davis, H   +5 more
core   +1 more source

The ERA-EDTA cohort study—comparison of methods to predict survival on renal replacement therapy [PDF]

open access: yes, 1997
Accurate prediction of patient survival from the time of starting renal replacement therapy (RRT) is desirable, but previously published predictive models have low accuracy.
Castelluccia, N.   +532 more
core   +10 more sources

A Distinct Urinary Biomarker Pattern Characteristic of Female Fabry Patients That Mirrors Response to Enzyme Replacement Therapy [PDF]

open access: yes, 2011
Female patients affected by Fabry disease, an X-linked lysosomal storage disorder, exhibit a wide spectrum of symptoms, which renders diagnosis, and treatment decisions challenging.
Breunig Frank   +69 more
core   +1 more source

Comparison of siRNA-mediated silencing of glycosaminoglycan synthesis genes and enzyme replacement therapy for mucopolysaccharidosis in cell culture studies [PDF]

open access: yes, 2012
Cytotoxicity of laronidase (Aldurazyme®), employed in enzyme replacement therapy (ERT) for mucopolysaccharidosis type I (MPS I) and various siRNAs, tested previously in studies on substrate reduction therapy (SRT) for mucopolysaccharidoses, was ...
Banecka-Majkutewicz, Zyta   +5 more
core   +2 more sources

The Choice of Dry Eye Therapy Depending on Ocular Surface Condition

open access: yesOftalʹmologiâ, 2021
Purpose: to develop approaches to differentiated substitution therapy in patients with dry eye (DE) of mild and moderate severity.Patients and methods. We examined 86 DE patients (22–45 years old; 38 men, 48 women). Group-1 included 54 patients (54 eyes)
S. V. Yanchenko   +2 more
doaj   +1 more source

Exploring challenges and considerations while providing hemodialysis to pediatric, elderly, and pregnant cases: A narrative review of globally published literature

open access: yesClinical Epidemiology and Global Health
Background: Hemodialysis patients have unique physiological characteristics that necessitate specialized care during the treatment. As the prevalence of kidney disease continues to rise, the importance of addressing the unique needs of these patient ...
Megha Nagaraj Nayak, Veena Natti Krishna
doaj   +1 more source

Case Report: Mucopolysaccharidosis Type I Treatment With α-L-Iduronidase Replacement Therapy

open access: yesFrontiers in Pediatrics, 2022
Mucopolysaccharidosis is a rare disease and can be divided into seven different subtypes, according to the affected enzyme. Mucopolysaccharidosis type I, the first subtype discovered and reported, mainly affects the in vivo storage of degraded sugar. The
Ying Li, Deyun Liu, Yue Yu
doaj   +1 more source

Home - About - Disclaimer - Privacy